Interleukin-34 and immune checkpoint inhibitors: Unified weapons against cancer.
Saved in:
| Title: | Interleukin-34 and immune checkpoint inhibitors: Unified weapons against cancer. |
|---|---|
| Authors: | Alshaebi F; Department of Respiratory, Shandong Second Provincial General Hospital, Shandong University, Jinan, Shandong, China., Safi M; Department of Respiratory, Shandong Second Provincial General Hospital, Shandong University, Jinan, Shandong, China., Algabri YA; Department of Biomedical Engineering, School of Control Science and Engineering, Shandong University, Jinan, Shandong, China., Al-Azab M; Department of Immunology, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou Medical University, Guangzhou, China., Aldanakh A; Department of Urology, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China., Alradhi M; Department of Urology, The Affiliated Hospital of Qingdao Binhai University, Qingdao, Shandong, China., Reem A; Faculty of Medicine and Health Sciences, Amran University, Amran, Yemen., Zhang C; Department of Respiratory, Shandong Second Provincial General Hospital, Shandong University, Jinan, Shandong, China. |
| Source: | Frontiers in oncology [Front Oncol] 2023 Jan 31; Vol. 13, pp. 1099696. Date of Electronic Publication: 2023 Jan 31 (Print Publication: 2023). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 36798830 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Interleukin-34 and immune checkpoint inhibitors: Unified weapons against cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Alshaebi+F%22">Alshaebi F</searchLink>; Department of Respiratory, Shandong Second Provincial General Hospital, Shandong University, Jinan, Shandong, China.<br /><searchLink fieldCode="AU" term="%22Safi+M%22">Safi M</searchLink>; Department of Respiratory, Shandong Second Provincial General Hospital, Shandong University, Jinan, Shandong, China.<br /><searchLink fieldCode="AU" term="%22Algabri+YA%22">Algabri YA</searchLink>; Department of Biomedical Engineering, School of Control Science and Engineering, Shandong University, Jinan, Shandong, China.<br /><searchLink fieldCode="AU" term="%22Al-Azab+M%22">Al-Azab M</searchLink>; Department of Immunology, Guangzhou Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou Medical University, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Aldanakh+A%22">Aldanakh A</searchLink>; Department of Urology, First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.<br /><searchLink fieldCode="AU" term="%22Alradhi+M%22">Alradhi M</searchLink>; Department of Urology, The Affiliated Hospital of Qingdao Binhai University, Qingdao, Shandong, China.<br /><searchLink fieldCode="AU" term="%22Reem+A%22">Reem A</searchLink>; Faculty of Medicine and Health Sciences, Amran University, Amran, Yemen.<br /><searchLink fieldCode="AU" term="%22Zhang+C%22">Zhang C</searchLink>; Department of Respiratory, Shandong Second Provincial General Hospital, Shandong University, Jinan, Shandong, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2023 Jan 31; Vol. 13, pp. 1099696. <i>Date of Electronic Publication: </i>2023 Jan 31 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36798830 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fonc.2023.1099696 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1099696 Titles: – TitleFull: Interleukin-34 and immune checkpoint inhibitors: Unified weapons against cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Alshaebi F – PersonEntity: Name: NameFull: Safi M – PersonEntity: Name: NameFull: Algabri YA – PersonEntity: Name: NameFull: Al-Azab M – PersonEntity: Name: NameFull: Aldanakh A – PersonEntity: Name: NameFull: Alradhi M – PersonEntity: Name: NameFull: Reem A – PersonEntity: Name: NameFull: Zhang C IsPartOfRelationships: – BibEntity: Dates: – D: 31 M: 01 Text: 2023 Jan 31 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 2234-943X Numbering: – Type: volume Value: 13 Titles: – TitleFull: Frontiers in oncology Type: main |
| ResultId | 1 |
